JOHNSON & JOHNSON | Therakos Photopheresis Station
This new design for the Therakos immune cell therapy unit greatly reduces the risks of infection, cross-contamination, and user errors and it cuts treatment time in half. The unit’s success recently enabled a transition to Mallinckrodt Pharmaceuticals.
View Website